Related Experiment Video
Updated: Jun 16, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Flavonoids: recent advances as anticancer drugs
Hai L Liu1, Wen B Jiang, Meng X Xie
1Analytical & Testing Center of Beijing Normal University, Beijing 100875, China.
Abstract:
Flavonoids belong to polyphenolic secondary metabolites with broad-spectrum pharmacological activities and extensive biological effects, and the most prominent activity is their potential role as anticancer agents. In recent years, flavonoids and their synthetic analogues have been intensely investigated in the treatment of ovarian, breast, cervical, pancreatic, and prostate cancer. To some extent, chemical structures of flavonoids will influence their anticancer activities. Thus, some new analogues based on the structural skeleton of these flavonoids have been synthesized and investigated. This review presents recent advances on the aspects of the natural flavonoids and their synthetic analogues in the treatment of cancers, and new synthetic approaches and possible structure-activity relationships of flavonoids are also briefly summarized.
Insights
Flavonoids show significant anticancer potential, especially in treating ovarian, breast, and prostate cancers. Research is exploring natural flavonoids and synthetic analogues for improved cancer therapies.
Area of Science:
- Biochemistry and Pharmacology
- Natural Product Chemistry
Background:
- Flavonoids are polyphenolic compounds with diverse pharmacological activities.
- Their anticancer properties are extensively studied for various cancer types.
Purpose of the Study:
- To review recent advances in natural flavonoids and synthetic analogues for cancer treatment.
- To summarize new synthetic approaches and structure-activity relationships.
Main Methods:
- Literature review of natural flavonoids and synthetic analogues.
- Analysis of structure-activity relationships in anticancer flavonoid research.
Main Results:
- Flavonoids exhibit broad-spectrum anticancer activity.
- Chemical structure significantly influences anticancer efficacy.
- Synthetic analogues are being developed to enhance therapeutic potential.
Conclusions:
- Flavonoids and their analogues represent a promising area for cancer drug development.
- Further research into structure-activity relationships can optimize flavonoid-based cancer therapies.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
